Cooper Companies | COO - Resultado Líquido

Preço das Ações
69.86
Mudança Diária
-0.31 -0.44%
Mensal
-7.86%
Anual
-4.71%
Q2 Previsão
68.06




Resultado Líquido Alterar Data
Abbott USD 1.78B 132M 2025-12
Align Technology USD 135.76M 79.01M 2025-12
AtriCure USD 1.76M 2.02M 2025-12
Avanos Medical USD -1.3M 100K 2025-12
Bausch Health Companies USD -112M 291M 2025-12
Baxter International USD -1.13B 1.08B 2025-12
Bayer EUR -3.76B 2.79B 2025-12
Becton, Dickinson and Co. USD 382M 111M 2025-12
Boston Scientific USD 672M 83M 2025-12
Cooper Companies USD 130.8M 46.2M 2025-12
Dentsply International USD -146M 281M 2025-12
Dexcom USD 267.3M 16.5M 2025-12
Edwards Lifesciences USD 91.2M 199.9M 2025-12
Globus Medical USD 140.59M 21.63M 2025-12
Haemonetics USD 44.74M 6.06M 2025-12
Hologic USD 179.1M 8.2M 2025-12
Inogen USD -5.96M 373K 2024-09
Insulet USD 101.6M 14M 2025-12
Integra LifeSciences USD -1.7M 3.7M 2025-12
Intuitive Surgical USD 794.8M 90.4M 2025-12
J&J USD 5.12B 36M 2025-12
Medtronic USD 1.14B 231M 2025-12
Merit Medical Systems USD 27.76M 4.83M 2025-09
Novartis USD 2.41B 1.52B 2025-12
ResMed USD 392.59M 44.06M 2025-12
STAAR Surgical USD -18.31M 27.19M 2025-12
Steris USD 192.9M 1000K 2025-12
Stryker USD 849M 10M 2025-12
Tandem Diabetes Care USD -589K 20.58M 2025-12
Teleflex USD -714.33M 305.44M 2025-12
Utah Medical Products USD 2.57M 445K 2025-12
Zimmer Biomet Holdings USD 139.3M 91.6M 2025-12